CodeSystem Comparison between http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution vs http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution

Messages

InformationCodeSystem.copyrightValues for copyright differ: 'This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license' vs 'This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').definitionChanged value for definition: '**Description:** Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.' vs 'Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').definitionChanged value for definition: '**Description:** Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.' vs 'Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').concept.where(code='EC').definitionChanged value for definition: '**Description:** Substitution occurred or is permitted with another product that is a: * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration *Examples:* * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate * *Pharmaceutical equivalent:* Lisonpril for Zestril' vs 'Substitution occurred or is permitted with another product that is a: * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration *Examples:* * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate * *Pharmaceutical equivalent:* Lisonpril for Zestril'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').concept.where(code='EC').concept.where(code='BC').definitionChanged value for definition: '**Description:** Substitution occurred or is permitted between equivalent Brands but not Generics *Examples:* * Zestril for Prinivil * Coumadin for Jantoven' vs 'Substitution occurred or is permitted between equivalent Brands but not Generics *Examples:* * Zestril for Prinivil * Coumadin for Jantoven'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').concept.where(code='EC').concept.where(code='G').definitionChanged value for definition: '**Description:** Substitution occurred or is permitted between equivalent Generics but not Brands *Examples:* * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)' vs 'Substitution occurred or is permitted between equivalent Generics but not Brands *Examples:* * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').concept.where(code='TE').definitionChanged value for definition: '**Description:** Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. *Examples:* * ranitidine for Tagamet' vs 'Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. *Examples:* * ranitidine for Tagamet'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').concept.where(code='TE').concept.where(code='TB').definitionChanged value for definition: '**Description:** Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > *Examples:* * Zantac for Tagamet' vs 'Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > *Examples:* * Zantac for Tagamet'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').concept.where(code='TE').concept.where(code='TG').definitionChanged value for definition: '**Description:** Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > *Examples:* * Ranitidine for cimetidine' vs 'Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > *Examples:* * Ranitidine for cimetidine'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='F').definitionChanged value for definition: '**Description:** This substitution was performed or is permitted based on formulary guidelines.' vs 'This substitution was performed or is permitted based on formulary guidelines.'

Metadata

NameValueComments
.caseSensitivetrue
    .compositional
      .contentcomplete
        .copyrightThis material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/licenseThis material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
        • Values Differ
        .date2019-03-20
          .descriptionIdentifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.
            .experimentalfalse
              .hierarchyMeaningis-a
                .jurisdiction
                  .nameSubstanceAdminSubstitution
                    .publisherHealth Level Seven International
                      .purpose
                        .statusactive
                          .titleSubstance Admin Substitution
                            .urlhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution
                              .version3.0.0
                                .versionNeeded

                                  Concepts

                                  CodeDisplaySpecializesGeneralizesinternalIdnotSelectablestatusSpecializesGeneralizesinternalIdnotSelectablestatusComments
                                  ._ActSubstanceAdminSubstitutionCodeActSubstanceAdminSubstitutionCode2128421284BooleanType[true]BooleanType[true]activeactive2128421284BooleanType[true]BooleanType[true]activeactive
                                  • definition changed from left to right